Ionis Pharmaceuticals (IONS) PT Lowered to $54 at Morgan Stanley
Tweet
Share
E-mailGet Alerts IONS Hot Sheet
Price: $73.82 +1.16%
Rating Summary:
19 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Rating Summary:
19 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Join SI Premium – FREE
Morgan Stanley analyst David Lebowitz lowered the price target on Ionis Pharmaceuticals (NASDAQ: IONS) to $54.00 (from $56.00) while maintaining a Underweight rating.
You May Also Be Interested In
- Goldman Sachs Upgrades Plains GP Holdings, L.P (PAGP) to Neutral
- Seiko Group Corp (8050:JP) PT Raised to JPY7,400 at Nomura/Instinet
- Abivax (ABVX) PT Lowered to $136 at Wolfe Research
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
